Daklinza 30 mg film-coated tablets Evrópusambandið - enska - myHealthbox

daklinza 30 mg film-coated tablets

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 30 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults

Daklinza 60 mg film-coated tablets Evrópusambandið - enska - myHealthbox

daklinza 60 mg film-coated tablets

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - film-coated tablet (tablet) - 60 mg - hepatitis c, chronic - direct-acting antiviral - indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults

OPDIVO 10 mg/mL concentrate for solution for infusion Bretland - enska - myHealthbox

opdivo 10 mg/ml concentrate for solution for infusion

bristol-myers squibb pharma eeig - nivolumab - concentrate for solution for infusion - 10 mg/ml - antineoplastic agents, monoclonal antibodies - as monotherapy is indicated for the treatment of advanced (unresectable or metastatic) melanoma in adults

Eliquis 2.5mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

eliquis 2.5mg tablets

bristol-myers squibb pharmaceuticals ltd - apixaban - tablet - 2.5mg

Eliquis 5mg tablets Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

eliquis 5mg tablets

bristol-myers squibb pharmaceuticals ltd - apixaban - tablet - 5mg

Daklinza Evrópusambandið - enska - EMA (European Medicines Agency)

daklinza

bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - hepatitis c, chronic - antivirals for systemic use - daklinza is indicated in combination with other medicinal products for the treatment of chronic hepatitis c virus (hcv) infection in adults (see sections 4.2, 4.4 and 5.1). for hcv genotype specific activity, see sections 4.4 and 5.1.,

FLORINEF 0.1 Milligram Tablets Írland - enska - HPRA (Health Products Regulatory Authority)

florinef 0.1 milligram tablets

bristol-myers squibb pharmaceuticals ltd - fludrocortisone acetate - tablets - 0.1 milligram

Nivolumab BMS Evrópusambandið - enska - EMA (European Medicines Agency)

nivolumab bms

bristol-myers squibb pharma eeig - nivolumab - carcinoma, non-small-cell lung - antineoplastic and immunomodulating agents, monoclonal antibodies - nivolumab bms is indicated for the treatment of locally advanced or metastatic squamous non-small cell lung cancer (nsclc) after prior chemotherapy in adults.

Zerit Evrópusambandið - enska - EMA (European Medicines Agency)

zerit

bristol-myers squibb pharma eeig - stavudine - hiv infections - antivirals for systemic use - hard capsuleszerit is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-infected adult patients and paediatric patients (over the age of three months) only when other antiretrovirals can not be used. the duration of therapy with zerit should be limited to the shortest time possible.powder for oral solutionzerit is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-infected adult patients and paediatric patients (from birth) only when other antiretrovirals can not be used. the duration of therapy with zerit should be limited to the shortest time possible.

Sustiva 100mg capsules Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

sustiva 100mg capsules

bristol-myers squibb pharmaceuticals ltd - efavirenz - capsule - 100mg